Metabolism follows a pathway that starts with a number of series of chemical reactions in a specific molecule in a sequential manner and finishes with a product that goes through specific enzymatic reactions. Enzymes are essential for most of the metabolic processes that allow the organism to carry chemical reactions in order to obtain the finished product and required energy.
Over 34% of Americans adults are estimated to be suffering from metabolic syndrome, CDC. Increasing prevalence of metabolic disorders and chronic diseases across the globe is driving the global metabolic testing market growth. However, stringent government regulations and longer time required for the approval of medical testing are expected to hinder the market growth to some extent. In addition, numerous product launches and a growing number of merger and acquisition activities in this field are expected to support the growth further.
The global metabolic testing market is segmented by technology, application, product, end user, and region.
By technology, the market is segmented into RMR analysis, VO2 max analysis, and body composition analysis. RMR analysis segment is expected to experience swift growth during the forecast period 2019–2026.
Based on application, the market is segmented into metabolic disorders, lifestyle diseases, human performance testing, critical care, dysmetabolic syndrome X, and others. Metabolic disorders segment is expected to hold a significant share of the market, owing to the rising prevalence of metabolic disorders across the globe.
On the basis of product, the market is segmented into software, CPET systems, ECGs/EKGs attachable to CPET systems, metabolic carts, and body composition analyzers. ECGs/EKGs attachable to CPET systems segment is expected to experience swift growth due to rising demand for CPET systems for the metabolic testing.
Based on end user, the market is segmented into hospitals, laboratories, sports training centers, and others. Amongst end user, sports training centers segment is expected to grow at an optimum pace in the coming years.
terms of region, the metabolic testing market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America.
Got questions about your regional growth of
Metabolic Testing Market?
Just drop us a line or call on +1 646 480 7505
North America is dominating the global metabolic testing market owing to developed healthcare infrastructure as it offers advanced testing facilities.
Europe is expected to grow significantly owing to the ongoing research & development regarding metabolic testing in the region. Presence of major players of the metabolic testing market is the additive factor which is anticipated to influence the market growth positively. Major players in the market are adopting advanced sales techniques such as collaborations with the distributors to gain higher market share in the market which, in turn, is developing potential opportunities for the metabolic testing market to grow in the region.
Asia Pacific market is expected to experience swift growth owing to the high population base along with the presence of a high number of people suffering from metabolic disorders.
Some of the key players in the global metabolic testing market are Parvo Medics, AEI Technologies, Inc., Microlife Medical Home Solutions, Inc., KORR Medical Technologies, Inc., General Electric Company, OSI Systems, Inc., Geratherm Medical AG, MGC Diagnostic Corporation, CORTEX Biophysik GmbH, COSMED, and CareFusion Corporation.
By End User
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast PeriodsView Full Report Buy This Report Now